moxifloxacin has been researched along with edetic acid in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 27,553 | 629 | 3,970 |
| Protein | Taxonomy | moxifloxacin (IC50) | edetic acid (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
| Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Majumdar, DK; Pawar, PK | 1 |
1 review(s) available for moxifloxacin and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for moxifloxacin and edetic acid
| Article | Year |
|---|---|
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Buffaloes; Chemistry, Pharmaceutical; Cornea; Edetic Acid; Fluoroquinolones; Goats; Hydrogen-Ion Concentration; Moxifloxacin; Permeability; Preservatives, Pharmaceutical; Quinolines; Sheep; Solubility | 2006 |